Aptahem AB (publ) (APTA.ST)
SEK 1.62
(0.94%)
SEK 1.62
(0.94%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.9 Million SEK | 114.38% |
| 2022 | -20.23 Million SEK | 56.25% |
| 2021 | -46.23 Million SEK | -61.89% |
| 2020 | -28.56 Million SEK | -30.56% |
| 2019 | -21.87 Million SEK | 25.08% |
| 2018 | -29.2 Million SEK | -18.28% |
| 2017 | -24.68 Million SEK | -17.73% |
| 2016 | -20.97 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -3.59 Million SEK | -2.8% |
| 2024 Q1 | -3.49 Million SEK | -220.3% |
| 2023 Q2 | -5.78 Million SEK | 40.5% |
| 2023 Q4 | 2.9 Million SEK | 199.82% |
| 2023 Q3 | -2.91 Million SEK | 49.6% |
| 2023 FY | 2.9 Million SEK | 114.38% |
| 2023 Q1 | -9.71 Million SEK | 51.96% |
| 2022 Q2 | -23.92 Million SEK | 40.34% |
| 2022 Q4 | -20.23 Million SEK | -5.55% |
| 2022 Q3 | -19.16 Million SEK | 19.87% |
| 2022 Q1 | -40.09 Million SEK | 13.28% |
| 2021 Q2 | -18.38 Million SEK | 0.0% |
| 2021 Q4 | -46.24 Million SEK | 13.3% |
| 2021 Q3 | -53.33 Million SEK | -190.08% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Asarina Pharma AB (publ) | -2.16 Million SEK | 234.597% |
| Vicore Pharma Holding AB (publ) | -333.62 Million SEK | 100.872% |
| NextCell Pharma AB | -46.79 Million SEK | 106.216% |
| Elicera Therapeutics AB (publ) | -29.38 Million SEK | 109.899% |
| Xbrane Biopharma AB (publ) | 166.07 Million SEK | 98.249% |
| AcouSort AB (publ) | -23.98 Million SEK | 112.126% |
| OncoZenge AB (publ) | -12.62 Million SEK | 123.035% |
| Xintela AB (publ) | -7.8 Million SEK | 137.247% |
| Ziccum AB (publ) | -2.13 Million SEK | 236.109% |
| Active Biotech AB (publ) | -33.2 Million SEK | 108.761% |
| Alzinova AB (publ) | -21.22 Million SEK | 113.703% |
| Amniotics AB (publ) | -5.63 Million SEK | 151.645% |
| Alligator Bioscience AB (publ) | -50.02 Million SEK | 105.815% |
| BioArctic AB (publ) | -606.58 Million SEK | 100.48% |
| Calliditas Therapeutics AB (publ) | 5.4 Million SEK | 46.136% |
| Camurus AB (publ) | -1.16 Billion SEK | 100.25% |
| Cantargia AB (publ) | -139.74 Million SEK | 102.081% |
| Scandinavian ChemoTech AB (publ) | -923 Thousand SEK | 415.129% |
| CombiGene AB (publ) | -101.44 Million SEK | 102.867% |
| Diamyd Medical AB (publ) | -82.08 Million SEK | 103.543% |
| Genovis AB (publ.) | -43.94 Million SEK | 106.619% |
| Guard Therapeutics International AB (publ) | -83.74 Million SEK | 103.473% |
| Mendus AB (publ) | -96.29 Million SEK | 103.021% |
| Isofol Medical AB (publ) | -138.14 Million SEK | 102.105% |
| Kancera AB (publ) | -45.69 Million SEK | 106.366% |
| Karolinska Development AB (publ) | -82.2 Million SEK | 103.538% |
| LIDDS AB (publ) | -13.51 Million SEK | 121.526% |
| Lipum AB (publ) | -8.46 Million SEK | 134.361% |
| Lipigon Pharmaceuticals AB (publ) | -31.92 Million SEK | 109.11% |
| Magle Chemoswed Holding AB (publ) | 53.22 Million SEK | 94.535% |
| Modus Therapeutics Holding AB (publ) | -19.06 Million SEK | 115.26% |
| Saniona AB (publ) | 40.44 Million SEK | 92.809% |
| Simris Alg AB (publ) | 85.07 Million SEK | 96.581% |
| Xspray Pharma AB (publ) | -129.49 Million SEK | 102.246% |
| Intervacc AB (publ) | -88.16 Million SEK | 103.299% |
| Sprint Bioscience AB (publ) | -49.93 Million SEK | 105.825% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | 20.51 Million SEK | 85.818% |
| Corline Biomedical AB | -17.01 Million SEK | 117.098% |
| IRLAB Therapeutics AB (publ) | -83.74 Million SEK | 103.473% |
| Bio-Works Technologies AB (publ) | -39.38 Million SEK | 107.386% |
| Infant Bacterial Therapeutics AB (publ) | -329.06 Million SEK | 100.884% |
| Fluicell AB (publ) | -2.76 Million SEK | 205.271% |
| Biovica International AB (publ) | -58.73 Million SEK | 104.952% |
| Spago Nanomedical AB (publ) | -45.21 Million SEK | 106.433% |
| Abliva AB (publ) | -57.24 Million SEK | 105.081% |
| Egetis Therapeutics AB (publ) | -194.7 Million SEK | 101.494% |
| 2cureX AB (publ) | -13.4 Million SEK | 121.701% |
| I-Tech AB | -83.26 Million SEK | 103.493% |
| Hansa Biopharma AB (publ) | 134.7 Million SEK | 97.841% |
| Cyxone AB (publ) | -16.67 Million SEK | 117.448% |
| ExpreS2ion Biotech Holding AB (publ) | -55.88 Million SEK | 105.205% |
| Biosergen AB | -1.88 Million SEK | 254.469% |
| Nanologica AB (publ) | -9.38 Million SEK | 130.983% |
| SynAct Pharma AB | -61.75 Million SEK | 104.71% |
| Annexin Pharmaceuticals AB (publ) | -21.41 Million SEK | 113.582% |
| BioInvent International AB (publ) | -236.3 Million SEK | 101.231% |
| Stayble Therapeutics AB (publ) | -13.22 Million SEK | 121.987% |
| Oncopeptides AB (publ) | -66.92 Million SEK | 104.346% |
| Pila Pharma AB (publ) | -5.18 Million SEK | 156.141% |
| Ascelia Pharma AB (publ) | -20.79 Million SEK | 113.989% |
| Diagonal Bio AB (publ) | -2.97 Million SEK | 197.868% |